149 related articles for article (PubMed ID: 22072226)
1. Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab.
Takezaki S; Okura Y; Ichikawa M; Suzuki D; Ohshima J; Kaneda M; Cho Y; Yamada M; Kawamura N; Iguchi A; Kobayashi I; Ariga T
Mod Rheumatol; 2012 Aug; 22(4):621-4. PubMed ID: 22072226
[TBL] [Abstract][Full Text] [Related]
2. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
Nerome Y; Imanaka H; Nonaka Y; Takei S
Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic experience with infliximab in a patient with polyarticular juvenile idiopathic arthritis and uveitis.
Mangge H; Heinzl B; Grubbauer HM; El-Shabrawi Y; Schauenstein K
Rheumatol Int; 2003 Sep; 23(5):258-61. PubMed ID: 12687288
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for systemic onset juvenile idiopathic arthritis: experience in 3 children.
Billiau AD; Cornillie F; Wouters C
J Rheumatol; 2002 May; 29(5):1111-4. PubMed ID: 12022340
[No Abstract] [Full Text] [Related]
5. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
[TBL] [Abstract][Full Text] [Related]
6. A case of planned pregnancy with an interruption in infliximab administration in a 27-year-old female patient with rheumatoid-factor-positive polyarthritis juvenile idiopathic arthritis which improved after restarting infliximab and methotrexate.
Nerome Y; Imanaka H; Nonaka Y; Tsuru Y; Maeno N; Takezaki T; Mori H; Akaike H; Kubota T; Kawano Y; Takei S
Mod Rheumatol; 2008; 18(2):189-92. PubMed ID: 18273538
[TBL] [Abstract][Full Text] [Related]
7. Atlanto-axial subluxation in a patient with polyarticular juvenile idiopathic arthritis: clinical and radiological response to infliximab.
Cannioto Z; Taddio A; Lepore L; Zennaro F
Clin Exp Rheumatol; 2008; 26(4):704-5. PubMed ID: 18799110
[No Abstract] [Full Text] [Related]
8. Infliximab for juvenile idiopathic arthritis-associated uveitis.
Richards JC; Tay-Kearney ML; Murray K; Manners P
Clin Exp Ophthalmol; 2005 Oct; 33(5):461-8. PubMed ID: 16181269
[TBL] [Abstract][Full Text] [Related]
9. High doses of infliximab in the management of juvenile idiopathic arthritis.
Tambralli A; Beukelman T; Weiser P; Atkinson TP; Cron RQ; Stoll ML
J Rheumatol; 2013 Oct; 40(10):1749-55. PubMed ID: 23950184
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids in juvenile idiopathic arthritis.
Malattia C; Martini A
Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
[TBL] [Abstract][Full Text] [Related]
11. Dosing of biologics in juvenile idiopathic arthritis: is the sky the limit?
Prince FH; Solomon DH
J Rheumatol; 2013 Oct; 40(10):1643-5. PubMed ID: 24085753
[No Abstract] [Full Text] [Related]
12. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P
Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
[TBL] [Abstract][Full Text] [Related]
13. Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan.
Hsin YC; Zhuang LZ; Yeh KW; Chang CW; Horng JT; Huang JL
PLoS One; 2015; 10(6):e0128768. PubMed ID: 26047099
[TBL] [Abstract][Full Text] [Related]
14. Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.
Ter Haar NM; van Dijkhuizen EHP; Swart JF; van Royen-Kerkhof A; El Idrissi A; Leek AP; de Jager W; de Groot MCH; Haitjema S; Holzinger D; Foell D; van Loosdregt J; Wulffraat NM; de Roock S; Vastert SJ
Arthritis Rheumatol; 2019 Jul; 71(7):1163-1173. PubMed ID: 30848528
[TBL] [Abstract][Full Text] [Related]
15. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis.
Barber J; Sheeran T; Mulherin D
Ann Rheum Dis; 2003 May; 62(5):490-1. PubMed ID: 12695170
[No Abstract] [Full Text] [Related]
17. Treatment of anorexia nervosa with TNF-α down-regulating agents.
Bou Khalil R; de Muylder O; Hebborn FL
Eat Weight Disord; 2011 Dec; 16(4):e300. PubMed ID: 22526138
[No Abstract] [Full Text] [Related]
18. Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.
Klotsche J; Raab A; Niewerth M; Sengler C; Ganser G; Kallinich T; Niehues T; Hufnagel M; Thon A; Hospach T; Horneff G; Minden K
Arthritis Rheumatol; 2016 Dec; 68(12):3023-3034. PubMed ID: 27332999
[TBL] [Abstract][Full Text] [Related]
19. Juvenile idiopathic arthritis in the new world of biologics.
Ostring GT; Singh-Grewal D
J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
[TBL] [Abstract][Full Text] [Related]
20. Update on the medical treatment of juvenile idiopathic arthritis.
Hashkes PJ; Laxer RM
Curr Rheumatol Rep; 2006 Dec; 8(6):450-8. PubMed ID: 17092444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
